메뉴 건너뛰기
British Journal of Haematology
Volumn 119, Issue 2, 2002, Pages 578-
Treatment of refractory autoimmune (acquired) haemophilia with anti-CD20 (rituximab) [5]
Author keywords

Factor VIII inhibitor; Refractory autoimmune (acquired) haemophilia; Rituximab
Indexed keywords

AZATHIOPRINE; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 INHIBITOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN; PREDNISOLONE; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RITUXIMAB; TRANEXAMIC ACID;
EID: 18744410921     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03835_5.x     Document Type: Letter
Times cited : (47)
References (7)
  • 1
    • 0034940321 scopus 로고    scopus 로고
    • Treatment of refractory autoimmune haemolytic anaemia with anti-CD20 (Rituximab)
    • Ahrens, N., Kingreen, D., Seltsam, A. & Salama, A. (2001) Treatment of refractory autoimmune haemolytic anaemia with anti-CD20 (Rituximab). British Journal of Haematology, 114, 244-245.
    • (2001) British Journal of Haematology , vol.114 , pp. 244-245
    • Ahrens, N.1    Kingreen, D.2    Seltsam, A.3    Salama, A.4
  • 2
    • 0026445919 scopus 로고
    • Lymphocytes: Phenotype, proliferation and differentiation
    • Banchereau, J., Rousset, F. & Human, B., (1992) Lymphocytes: phenotype, proliferation and differentiation. Advances in Immunology, 52, 125-262.
    • (1992) Advances in Immunology , vol.52 , pp. 125-262
    • Banchereau, J.1    Rousset, F.2    Human, B.3
  • 3
    • 0003258420 scopus 로고    scopus 로고
    • Treatment of acquired factor VIII deficiency with rituximab
    • Abstract 2232
    • Karwal, M.W., Schlueter, A.J., Zenk, D.W. & Davis, R.T. (2001) Treatment of acquired factor VIII deficiency with rituximab. Blood, 98 (11), Suppl. 1, Abstract 2232.
    • (2001) Blood , vol.98 , Issue.11 SUPPL. 1
    • Karwal, M.W.1    Schlueter, A.J.2    Zenk, D.W.3    Davis, R.T.4
  • 4
    • 0033549067 scopus 로고    scopus 로고
    • IgM antibody-related ply-neuropathies: B-cell depletion chemotherapy using rituximab
    • Levine, T.D. & Pestronk, A. (1999) IgM antibody-related ply-neuropathies: B-cell depletion chemotherapy using rituximab. Neurology, 52, 1701-1704.
    • (1999) Neurology , vol.52 , pp. 1701-1704
    • Levine, T.D.1    Pestronk, A.2
  • 5
    • 0034909628 scopus 로고    scopus 로고
    • Remission of cold hemagglutinin disease induced by rituximab therapy
    • Sparling, T.G., Andricevic, M. & Wass, H. (2001) Remission of cold hemagglutinin disease induced by rituximab therapy. CMAJ, 164 (10), 1405.
    • (2001) CMAJ , vol.164 , Issue.10 , pp. 1405
    • Sparling, T.G.1    Andricevic, M.2    Wass, H.3
  • 6
    • 0035883071 scopus 로고    scopus 로고
    • Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura
    • Stasi, R., Pagano, A., Stipa, E. & Amadori, S. (2001) Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood, 98, 952-957.
    • (2001) Blood , vol.98 , pp. 952-957
    • Stasi, R.1    Pagano, A.2    Stipa, E.3    Amadori, S.4
  • 7
    • 79960971755 scopus 로고    scopus 로고
    • Rituximab in treatment of acquired factor VIII inhibitors
    • Abstract 2233
    • Wiestner, A., Cho, H.J. & Asch, A.S. (2001) Rituximab in treatment of acquired factor VIII inhibitors. Blood, 98 (11), Suppl 1, Abstract 2233.
    • (2001) Blood , vol.98 , Issue.11 SUPPL. 1
    • Wiestner, A.1    Cho, H.J.2    Asch, A.S.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.